NewsBlog: Clinical diagnostics in a Starbucks package Posted by Brendan Maher [Entry posted at 13th April 2006 08:20 PM GMT] The New York Times has an interesting business story on the growth of high-priced clinical diagnostic tests involving genomic and proteomic technologies. One chief scientific officer praised the makers of Oncotype DX (which rates the risk of breast cancer recurrence based on a panel of 12 genes) for validating their product in the clinic and then placing it ?in a Starbucks package at a high price.? At $3500 a pop, the test... Click to continue Comment on this blog

Brendan Maher Location: Philadelphia, USA Who am I? Editor at The Scientist Previous months >>   May 2007 >>   April 2007 >>   March 2007 >>   February 2007 >>   January 2007 >>   December 2006 >>   November 2006 >>   October 2006 >>   September 2006 >>   August 2006 >>   July 2006 >>   June 2006 >>   May 2006 >>   April 2006 >>   March 2006 >>   February 2006 >>   January 2006 >>   December 2005 >>   November 2005 >>   October 2005 >>   September 2005 >>   August 2005 >>   July 2005 >>   June 2005